Overview
Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
Status:
Completed
Completed
Trial end date:
2005-03-01
2005-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the safety and efficacy of VEC-162 compared to matching placebo on circadian phase shift and sleep parameters.Phase:
Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Vanda Pharmaceuticals
Criteria
Inclusion Criteria:- No medical, psychiatric, or sleep disorders
- Ability to provide written informed consent
Exclusion Criteria:
- Lifetime history of night shift work
- Evidence of any sleep disorder
- Psychiatric or neurological disorders